Ineligible Issuer Status. The Company is not an “ineligible issuer” in connection with the offering of the Shares pursuant to Rules 164, 405 and 433 under the Securities Act.
Appears in 8 contracts
Samples: Open Market Sale Agreement (VBI Vaccines Inc/Bc), Equity Distribution Agreement (Tilray Brands, Inc.), Open Market Sale Agreement (Postal Realty Trust, Inc.)
Ineligible Issuer Status. The Company is not an “ineligible issuer” in connection with the offering of the Shares Securities pursuant to Rules 164, 405 and 433 under the Securities Act.
Appears in 6 contracts
Samples: Securities Purchase Agreement (ImmunityBio, Inc.), Securities Purchase Agreement (ImmunityBio, Inc.), Securities Purchase Agreement (ImmunityBio, Inc.)
Ineligible Issuer Status. The Company is not an “ineligible issuer” in connection with the offering of the Shares pursuant to Rules 164, 405 and 433 under the Securities Act.
Appears in 5 contracts
Samples: Sales Agreement (Orchestra BioMed Holdings, Inc.), Open Market Sale Agreement (Orchestra BioMed Holdings, Inc.), Open Market Sale Agreement (Waitr Holdings Inc.)
Ineligible Issuer Status. The Company was not and is not an “ineligible issuer” issuer as defined in Rule 405 under the Securities Act at the times specified in Rules 164 and 433 under the Securities Act in connection with the offering of the Shares pursuant to Rules 164, 405 and 433 under the Securities ActShares.
Appears in 3 contracts
Samples: Sales Agreement (Global Medical REIT Inc.), Sales Agreement (Global Medical REIT Inc.), Sales Agreement (Global Medical REIT Inc.)
Ineligible Issuer Status. The Company is not an “ineligible issuer” in connection with the offering of the Shares Securities pursuant to Rules Rule 164, 405 and 433 under the Securities Act.
Appears in 1 contract
Ineligible Issuer Status. The Company is not an “ineligible issuer” in connection with the offering of the Shares Securities pursuant to Rules 164, 405 and 433 under the Securities Act of 1933, as amended (the “Securities Act”).
Appears in 1 contract
Samples: Securities Purchase Agreement (Enliven Therapeutics, Inc.)
Ineligible Issuer Status. The Company is not an “ineligible issuer” in connection with the offering of the Shares and Forward Settlement Shares pursuant to Rules 164, 405 and 433 under the Securities Act.. 276938411 v5
Appears in 1 contract
Samples: Open Market Sale Agreement (Postal Realty Trust, Inc.)
